The results showed that after adjusting for other factors (NE, ALT, AST, cardiovascular and cerebrovascular diseases), we still did not find a statistical difference between therapy with convalescent plasma and therapy without convalescent plasma. This evidence concerns the gene GPT and cerebrovascular disorder.